What is the recommended radiation dose and target volume delineation for definitive external-beam radiotherapy in a patient with sinonasal inverted papilloma presenting with gross disease?

Radiation Dose and Volume for Sinonasal Inverted Papilloma with Gross Disease

For sinonasal inverted papilloma with gross disease requiring definitive radiotherapy, deliver 65-70 Gy in conventional fractionation (1.8-2.0 Gy per fraction) to the gross tumor volume (GTV) plus a 1-2 cm margin for the clinical target volume (CTV). 1, 2

Target Volume Delineation

Gross Tumor Volume (GTV)

• Define the GTV using high-quality MRI fused with CT simulation, as MRI demonstrates superior detection of skull base extension, perineural disease, and marrow infiltration compared to CT alone 3, 4
• The GTV encompasses all visible tumor on imaging and clinical examination 5, 4

Clinical Target Volume (CTV)

• Expand the GTV by 1-2 cm to create the CTV, accounting for microscopic disease extension that cannot be visualized on imaging 6
• This margin is based on historical data showing subclinical tumor spread patterns in sinonasal tumors 4
• For inverted papilloma specifically, the CTV should encompass the entire site of origin and areas of potential microscopic spread 1, 2

Planning Target Volume (PTV)

• Add a margin of 1.65 standard deviations (typically 3-5 mm) around the CTV to create the PTV, which accounts for setup uncertainties and organ motion 7
• This margin ensures that 95% of the time, any point on the CTV surface remains within the PTV during treatment delivery 7

Dose Prescription

Definitive Radiotherapy for Gross Disease

• Prescribe 65-70 Gy to the PTV using conventional fractionation (1.8-2.0 Gy per fraction over 6.5-7 weeks) 1, 2
• The median dose of 65 Gy has demonstrated long-term local control in retrospective series 1
• Do not exceed 70 Gy with conventional fractionation, as higher doses increase the risk of severe late toxicities including radionecrosis, particularly in the sinonasal region 6, 8

Postoperative Radiotherapy

• For incompletely resected disease (R1/R2 resection), deliver 60-66 Gy to areas of residual disease 6, 1
• Microscopic residual disease (R1): 60-63 Gy 6
• Gross residual disease (R2): 64-66 Gy 6

Elective Nodal Coverage

• Elective nodal irradiation is generally not required for inverted papilloma, as nodal metastases are exceedingly rare in the absence of malignant transformation 1, 2
• If squamous cell carcinoma is present (IP-SCC), treat involved nodes to 70 Gy and elective nodal regions to 50-54 Gy 8, 9

Technical Delivery Considerations

Imaging Requirements

• MRI-CT fusion is mandatory for accurate target delineation, particularly for assessing skull base involvement and intracranial extension 3, 10
• Obtain both pre-operative and post-operative imaging to define the extent of disease and surgical bed 6

Fractionation Strategy

• Use conventional fractionation (1.8-2.0 Gy per fraction) delivered once daily 1, 2
• Twice-daily hyperfractionation has been used in select cases but offers no proven advantage for inverted papilloma 1

Treatment Technique

• Employ intensity-modulated radiotherapy (IMRT) to optimize dose distribution and spare adjacent critical structures including the optic apparatus, brain, and brainstem 8, 3
• IMRT reduces long-term toxicity to surrounding normal tissues while maintaining target coverage 8

Critical Pitfalls to Avoid

• Do not treat inverted papilloma without pathologic confirmation, as imaging alone cannot reliably distinguish IP from other sinonasal masses including malignancy 6, 11
• Do not use CT alone for treatment planning—MRI fusion is essential for accurate delineation of skull base and intracranial involvement 3, 10
• Do not reduce the CTV margin below 1 cm, as inverted papilloma has a high propensity for local recurrence due to microscopic extension 1, 2
• Do not exceed 70 Gy with standard fractionation, as this significantly increases the risk of severe complications including CNS radionecrosis 6, 8, 1
• Do not omit long-term surveillance after treatment, as recurrence can occur years after initial therapy and early detection allows for easier salvage 1, 11

Special Considerations

Malignant Transformation

• If squamous cell carcinoma is present (IP-SCC), treat as a high-grade sinonasal malignancy with 70 Gy to gross disease and consider concurrent chemotherapy for locally advanced disease 8, 1
• IP-SCC has significantly worse outcomes than benign IP, with 15-year local control rates of only 16% versus 80% for IP alone 1

Multiply Recurrent Disease

• Radiation therapy should be strongly considered for multiply recurrent inverted papilloma, even in the absence of malignancy, as surgical salvage becomes increasingly difficult with each recurrence 1, 2
• Incompletely resectable disease at critical anatomic sites (skull base, orbit) represents another clear indication for radiotherapy 1, 2